Supplements · Longevity & mitochondrial

NMN (nicotinamide mononucleotide)

Also known as: Nicotinamide mononucleotide, beta-NMN, NAD+ precursor

NMN is a precursor to NAD+ sold for healthy ageing. It raises NAD+ in humans, but proof of real-world benefits is thin and its legal status is unsettled.

longevityenergy
Typical dose
Commonly 250-500 mg a day in supplements and studies; some products go higher
Best taken
Often taken in the morning; some take it with food to reduce stomach upset
Onset
Blood NAD+ rises within days to weeks; noticeable effects are uncertain
Common forms
Capsules, powder, sublingual tablets
Storage
Cool, dry and away from light; some brands recommend refrigerating the powder

Read this first

This is general information, not medical advice. Supplements can interact with medicines and aren’t suitable for everyone, especially in pregnancy or with a medical condition. Talk to a pharmacist or doctor before starting one.

What it is

Nicotinamide mononucleotide (NMN) is a molecule your body uses to make NAD+, a coenzyme involved in energy metabolism and cell repair. NAD+ levels appear to fall with age, which is why NMN became popular in the longevity world.

Much of the excitement comes from animal studies, mainly in mice. Human research exists but is smaller and shorter, and mostly measures blood markers rather than long-term health outcomes.

It is closely related to nicotinamide riboside (NR) and to the injectable NAD+ discussed elsewhere on this site.

How it works

The body converts NMN into NAD+ through a short pathway. NAD+ is used in energy production and by enzymes involved in DNA repair and cell signalling. Whether raising blood NAD+ translates into meaningful health effects in people is still being studied.

What the evidence says

  • Moderate Raising NAD+ levels in blood
    Several small human trials show NAD+ metabolites rise with oral NMN.
  • Limited Physical performance or muscle function in older adults
    Some small trials report modest improvements in walking or strength measures; results are not consistent.
  • Limited Insulin sensitivity
    A small study in a specific group (postmenopausal women with prediabetes) showed an effect on muscle insulin signalling; it is far from conclusive.
  • Weak Slowing ageing or extending lifespan
    Animal findings have not been shown to carry over to humans, and no human lifespan data exist.

Evidence ratings are our plain-English summary of how much good human research exists, not a promise of results. How we rate evidence.

Dosage and timing

  • Most supplements supply 250-500 mg per day; higher doses are sold but have little extra proof behind them.
  • Timing is not well established; morning is common because NAD+ is linked to energy.
  • Study durations are short (weeks to months), so long-term use is unstudied.
  • There is no official recommended intake; check current guidance and speak to a clinician if you have a medical condition.

Forms and what to look for

  • Capsules are the simplest and most widely used format.
  • Powder is cheaper per gram but harder to dose accurately.
  • Sublingual products are marketed for better absorption; evidence that they are superior is limited.
  • Check the label for beta-NMN content and purity; avoid vague blends.

What to expect, and when

  • Blood NAD+ markers can rise within a couple of weeks.
  • Many people report no noticeable change; any effect on energy is hard to separate from placebo.
  • Studies looking at function tend to run 8-12 weeks or longer.

Side effects

  • Generally well tolerated in short human trials.
  • Nausea, stomach discomfort or diarrhoea in some people.
  • Flushing, headache or restlessness reported.
  • Long-term effects in humans are unknown.

Interactions

  • No well-established interactions, but data are limited.
  • Diabetes medicines: NMN might affect glucose handling, so monitor if relevant.
  • Other NAD+ boosters such as niacin or nicotinamide riboside: stacking them has no proven advantage.
  • Cancer treatment: because NAD+ supports cell growth, check with your oncology team first.

Who should avoid it

  • Pregnant or breastfeeding women, due to lack of safety data.
  • People with a current or past cancer diagnosis, unless cleared by their clinician.
  • Children and teenagers.
  • Anyone on regular medication should speak to a pharmacist or doctor first.

Risks and safety

  • Regulatory status is unclear and changes. In the UK and EU, NMN is generally treated as a novel food and has not been authorised; products may be removed from sale. Check current Food Standards Agency and EU guidance.
  • In the US, the FDA has taken the position that NMN was excluded from the supplement definition because it was investigated as a drug; this has been contested and developments continue, so check the current position.
  • Because of the grey legal area, product quality varies and some products may be mislabelled.
  • Unregulated, high-dose and injectable NMN products sold online carry added risk.

Buying well: quality and testing

  • Look for independent lab testing (certificate of analysis) showing NMN content and purity.
  • Be wary of sellers making anti-ageing or cure claims.
  • Check whether a seller is a UK or EU registered business and what novel-food position they claim.
  • Compare cost per 250 mg; very cheap products may be underdosed or degraded.

Bottom line

NMN reliably raises NAD+ markers, but the leap from there to feeling younger or living longer has not been demonstrated in people. The legal position in the UK and EU is uncertain, so check current status before buying. For most people it is an expensive experiment with an unproven payoff; if you try it, buy from a tested, transparent supplier and speak to a clinician if you have health conditions.